Axim Cases and Covers in the News

Mon, 23 Apr 2018 01:22:41 GMT
This RSS feed URL is deprecatedThis RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Thu, 19 Apr 2018 12:44:27 GMT
Green Market Cannabis Index Plunges In Q1 As Regulatory Worries Weighed On Investors' Minds - Green Market Report

Green Market Report

Green Market Cannabis Index Plunges In Q1 As Regulatory Worries Weighed On Investors' Minds
Green Market Report
Instead, Prime Minister Justin Trudeau and his team have hinted that recreational use could start in the fall, as opposed to July, as had been previously thought. Much of the downfall seen in the U.S-based stocks occurred due to a correction in the so ...

and more »


Tue, 27 Feb 2018 15:35:56 GMT
Axim to patent GMP methods for 'pure' cannabis APIs - In-PharmaTechnologist.com

In-PharmaTechnologist.com

Axim to patent GMP methods for 'pure' cannabis APIs
In-PharmaTechnologist.com
The US-headquartered firm developed and tested the current good manufacturing practice (cGMP) methods in the Netherlands, under the country's regulated guidelines. “In the Netherlands, professional cultivation of cannabis is legal, therefore allowing ...

and more »


Tue, 13 Feb 2018 18:53:23 GMT
CHRAJ records high number of non-maintenance of children - GhanaWeb

CHRAJ records high number of non-maintenance of children
GhanaWeb
The Western Regional Office of the Commission for Human Rights and Administrative Justice (CHRAJ) continue to record high rates of non-maintenance of children in some districts. Nana Jomfoah Amua-Sekyi, CHRAJ Regional Director, who made this known to ...



Wed, 23 Nov 2016 16:11:44 GMT
Marijuana Stocks: Short AXIM Biotechnologies...If You Can Borrow And Finance The Shares - Seeking Alpha

Marijuana Stocks: Short AXIM Biotechnologies...If You Can Borrow And Finance The Shares
Seeking Alpha
AXIM has [1] a negative working capital position, [2] toxic convertibles, and [3] a negative gross profit on meager revenues. Fidelity indicates that AXIM shares are [1] “hard to borrow” and [2] charges a 6.5% annual interest rate to maintain a short ...



Wed, 07 Feb 2018 17:46:20 GMT
268 Marijuana Stocks: Learn From An Examination Of Event Dates For The Prior 52 Weeks - Seeking Alpha

Washington Post

268 Marijuana Stocks: Learn From An Examination Of Event Dates For The Prior 52 Weeks
Seeking Alpha
The DOW was down 8.5% from record highs at the close on Monday, February 5, 2018; the public watches and reacts to the DOW. A partial recovery occurred on Tuesday, February 6, 2018; I started capturing data used for this article at the close of ...
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010 | Law and Medicine ...The JAMA Network
In Tampa visit, Attorney General Jeff Sessions recommends aspirin over opioids for pain reliefTampabay.com
Link Between Medical Marijuana and Fewer Opioid Deaths Is More Complex Than Previously Reported | RANDRAND Corporation
The Week Magazine
all 112 news articles »


Thu, 14 Sep 2017 08:04:11 GMT
Biosynthesis Technology Could Transform Cannabinoid Production - Markets Insider

Biosynthesis Technology Could Transform Cannabinoid Production
Markets Insider
... within the burgeoning sector, including Axim Biotechnologies, Inc. (OTC: AXIM), GW Pharmaceuticals (NASDAQ: GWPH), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) and pharmaceutical heavyweight Eli Lilly and Company (NYSE: LLY). Perhaps the clearest ...

and more »


Thu, 22 Feb 2018 15:21:29 GMT
The 5 Hidden Risks of Owning Marijuana Stocks - Motley Fool

The 5 Hidden Risks of Owning Marijuana Stocks
Motley Fool
In case you haven't noticed, marijuana stocks have been practically unstoppable over the past year. Even with a recent pullback, many of the largest pot stocks (i.e., those with market caps in excess of $200 million in market cap) have doubled or ...

and more »


Tue, 21 Mar 2017 13:02:03 GMT
AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye ... - GlobeNewswire (press release)

GlobeNewswire (press release)

AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye ...
GlobeNewswire (press release)
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has retained the services of Ora®, Inc., a global Contract Research ...

and more »


Wed, 18 May 2016 10:24:26 GMT
Lou Moon Lodge - Telegraph.co.uk

Telegraph.co.uk

Lou Moon Lodge
Telegraph.co.uk
Light-filled rooms with high vaulted ceilings feature hardwood or polished cement floors in ochre and cream; nearly every room has a private terrace, deck or verandah and views of the ocean. Two of the island villas have their own clifftop infinity ...



Fri, 01 Dec 2017 04:28:53 GMT
GridIron BioNutrients (MYYZ) Bioceutical Breakthrough May Hold the Key to the NFL's Deadly CTE Crisis - MMJ Observer

GridIron BioNutrients (MYYZ) Bioceutical Breakthrough May Hold the Key to the NFL's Deadly CTE Crisis
MMJ Observer
Who will step up and become the next MMJ company to go ballistic? The obvious candidates include Axim Biotechnologies (OTC: AXIM), Golden Leaf (OTC: GLDFF), and GridIron BioNutrients (MYYZ). NFL Can't Dodge The Need for Help. CTE or chronic traumatic ...